{"disease":{"id":"block","name":"block"},"drugs":{"marketed":[{"drug_id":"upadacitinib","indication_name":"Active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older with inadequate response or intolerance to TNF blockers","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rinvoq","generic_name":"upadacitinib","company_name":"AbbVie Inc.","drug_phase":"marketed","molecular_target":"Janus kinase (JAK) enzymes, particularly JAK1 and JAK2","drug_class":"JAK inhibitor","quality_score":86,"revenue":"5300","mechanism":"JAK inhibitor that prevents STAT phosphorylation and activation in cytokine signaling pathways."},{"drug_id":"upadacitinib","indication_name":"Moderately to severely active rheumatoid arthritis in adults with inadequate response or intolerance to TNF blockers","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rinvoq","generic_name":"upadacitinib","company_name":"AbbVie Inc.","drug_phase":"marketed","molecular_target":"Janus kinase (JAK) enzymes, particularly JAK1 and JAK2","drug_class":"JAK inhibitor","quality_score":86,"revenue":"5300","mechanism":"JAK inhibitor that prevents STAT phosphorylation and activation in cytokine signaling pathways."},{"drug_id":"upadacitinib","indication_name":"Active psoriatic arthritis in adults with inadequate response or intolerance to TNF blockers","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rinvoq","generic_name":"upadacitinib","company_name":"AbbVie Inc.","drug_phase":"marketed","molecular_target":"Janus kinase (JAK) enzymes, particularly JAK1 and JAK2","drug_class":"JAK inhibitor","quality_score":86,"revenue":"5300","mechanism":"JAK inhibitor that prevents STAT phosphorylation and activation in cytokine signaling pathways."},{"drug_id":"upadacitinib","indication_name":"Active psoriatic arthritis in pediatric patients 2 years of age and older with inadequate response or intolerance to TNF blockers","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rinvoq","generic_name":"upadacitinib","company_name":"AbbVie Inc.","drug_phase":"marketed","molecular_target":"Janus kinase (JAK) enzymes, particularly JAK1 and JAK2","drug_class":"JAK inhibitor","quality_score":86,"revenue":"5300","mechanism":"JAK inhibitor that prevents STAT phosphorylation and activation in cytokine signaling pathways."},{"drug_id":"upadacitinib","indication_name":"Moderately to severely active ulcerative colitis in adults with inadequate response or intolerance to TNF blockers","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rinvoq","generic_name":"upadacitinib","company_name":"AbbVie Inc.","drug_phase":"marketed","molecular_target":"Janus kinase (JAK) enzymes, particularly JAK1 and JAK2","drug_class":"JAK inhibitor","quality_score":86,"revenue":"5300","mechanism":"JAK inhibitor that prevents STAT phosphorylation and activation in cytokine signaling pathways."},{"drug_id":"upadacitinib","indication_name":"Moderately to severely active Crohn's disease in adults with inadequate response or intolerance to TNF blockers","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rinvoq","generic_name":"upadacitinib","company_name":"AbbVie Inc.","drug_phase":"marketed","molecular_target":"Janus kinase (JAK) enzymes, particularly JAK1 and JAK2","drug_class":"JAK inhibitor","quality_score":86,"revenue":"5300","mechanism":"JAK inhibitor that prevents STAT phosphorylation and activation in cytokine signaling pathways."},{"drug_id":"upadacitinib","indication_name":"Active ankylosing spondylitis in adults with inadequate response or intolerance to TNF blockers","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rinvoq","generic_name":"upadacitinib","company_name":"AbbVie Inc.","drug_phase":"marketed","molecular_target":"Janus kinase (JAK) enzymes, particularly JAK1 and JAK2","drug_class":"JAK inhibitor","quality_score":86,"revenue":"5300","mechanism":"JAK inhibitor that prevents STAT phosphorylation and activation in cytokine signaling pathways."},{"drug_id":"upadacitinib","indication_name":"Active non-radiographic axial spondyloarthritis with objective signs of inflammation in adults with inadequate response or intolerance to TNF blockers","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rinvoq","generic_name":"upadacitinib","company_name":"AbbVie Inc.","drug_phase":"marketed","molecular_target":"Janus kinase (JAK) enzymes, particularly JAK1 and JAK2","drug_class":"JAK inhibitor","quality_score":86,"revenue":"5300","mechanism":"JAK inhibitor that prevents STAT phosphorylation and activation in cytokine signaling pathways."},{"drug_id":"bupivacain","indication_name":"Local anesthetic intrathecal block","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Bupivacain","company_name":"Sisli Hamidiye Etfal Training and Research Hospital","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Cytochrome P450 2D6, Potassium channel subfamily K member 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"bupivacain","indication_name":"Major Nerve Block for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Bupivacain","company_name":"Sisli Hamidiye Etfal Training and Research Hospital","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Cytochrome P450 2D6, Potassium channel subfamily K member 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"lignocaine","indication_name":"Local anesthetic intrathecal block","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lignocaine","company_name":"University of Malaya","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"ropivacain","indication_name":"Major Nerve Block for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ropivacain","company_name":"University Hospital, Basel, Switzerland","drug_phase":"marketed","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"naropine","indication_name":"Major Nerve Block for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naropine","company_name":"Rigshospitalet, Denmark","drug_phase":"phase_1","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lidocaine-hydrochloride","indication_name":"Local anesthetic intrathecal block","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lignospan Forte","generic_name":"Lidocaine Hydrochloride","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"neuronal membrane ionic channels","drug_class":"local anesthetic, amide type","quality_score":68,"revenue":null,"mechanism":"Lidocaine stabilizes neuronal membrane by inhibiting ionic fluxes required for impulse initiation and conduction."},{"drug_id":"naropeine","indication_name":"Major Nerve Block for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naropeine","company_name":"University Hospital, Rouen","drug_phase":"phase_3","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"epinephrine","indication_name":"Administration of Local Anesthetic Nerve Block","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Epipen","generic_name":"epinephrine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Alpha-1D adrenergic receptor","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":80,"revenue":null,"mechanism":"Epipen works by stimulating the alpha-1D adrenergic receptor to rapidly increase heart rate, blood pressure, and bronchodilation."},{"drug_id":"articaine","indication_name":"Administration of Local Anesthetic Nerve Block","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Septocaine","generic_name":"ARTICAINE","company_name":"","drug_phase":"marketed","molecular_target":"Sodium channel alpha subunits; brain (Types I, II, III)","drug_class":"Amide Local Anesthetic","quality_score":65,"revenue":null,"mechanism":"Articaine HCl blocks nerve impulses by increasing the threshold for electrical excitation, slowing nerve impulse propagation, and reducing the rate of rise of the action potential."},{"drug_id":"edrophonium","indication_name":"Neuromuscular Block due to Nondepolarizing Drug","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tensilon","generic_name":"EDROPHONIUM","company_name":"","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"Cholinesterase Inhibitor","quality_score":36,"revenue":null,"mechanism":""},{"drug_id":"edrophonium","indication_name":"Reversal of neuromuscular blockade","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tensilon","generic_name":"EDROPHONIUM","company_name":"","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"Cholinesterase Inhibitor","quality_score":36,"revenue":null,"mechanism":""},{"drug_id":"lidocaine-hydrochloride-and-epinephrine","indication_name":"Administration of Local Anesthetic Nerve Block","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"Epinephrine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Alpha-1D adrenergic receptor","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":80,"revenue":null,"mechanism":"Epinephrine works by stimulating the alpha-1D adrenergic receptor to increase heart rate and blood pressure, and to constrict blood vessels."},{"drug_id":"isoprenaline","indication_name":"Atrioventricular block","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Isuprel","generic_name":"isoprenaline","company_name":"","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta-Adrenergic Agonist","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"isoprenaline","indication_name":"Syncope due to Heart Block","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Isuprel","generic_name":"isoprenaline","company_name":"","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta-Adrenergic Agonist","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"levobupivacaine","indication_name":"Major Nerve Block for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chirocain","generic_name":"LEVOBUPIVACAINE","company_name":"Purdue Pharma Lp","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"levobupivacaine","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"tetracaine","indication_name":"Local anesthetic intrathecal block","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tetracaine Hydrochloride","generic_name":"TETRACAINE","company_name":"Alcon Labs","drug_phase":"marketed","molecular_target":"Sodium channel protein type 7 subunit alpha","drug_class":"Ester Local Anesthetic","quality_score":10,"revenue":null,"mechanism":"Tetracaine Hydrochloride works by blocking sodium channels in nerve cells to prevent pain signals from being transmitted."},{"drug_id":"epinephrin","indication_name":"Administration of Local Anesthetic Nerve Block","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Epinephrin","company_name":"United States Naval Medical Center, San Diego","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"carbocaine","indication_name":"Administration of Local Anesthetic Nerve Block","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Carbocaine","company_name":"Nantes University Hospital","drug_phase":"marketed","molecular_target":"Sodium channel protein type 1 subunit alpha, Sodium channel protein type 2 subunit alpha, Sodium channel protein type 3 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lidocain","indication_name":"Local anesthetic intrathecal block","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lidocain","company_name":"Bayer","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"xylocain","indication_name":"Local anesthetic intrathecal block","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"xylocain","company_name":"Saint-Joseph University","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"bupivacaine-hydrochloride-and-epinephrine","indication_name":"Local anesthetic intrathecal block","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride","generic_name":"Bupivacaine Hydrochloride","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Nerve sodium channels","drug_class":"Amide-type local anesthetic","quality_score":10,"revenue":null,"mechanism":"Bupivacaine blocks nerve impulse generation and conduction by increasing electrical excitation threshold and slowing action potential rise."},{"drug_id":"prednisone","indication_name":"Tuberculous meningitis with subarachnoid block","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"bupivacaine-hydrochloride-and-epinephrine","indication_name":"Major Nerve Block for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride","generic_name":"Bupivacaine Hydrochloride","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Nerve sodium channels","drug_class":"Amide-type local anesthetic","quality_score":10,"revenue":null,"mechanism":"Bupivacaine blocks nerve impulse generation and conduction by increasing electrical excitation threshold and slowing action potential rise."},{"drug_id":"dexamethasone-phosphate","indication_name":"Tuberculous meningitis with subarachnoid block","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dexamethasone Sodium Phosphate","generic_name":"dexamethasone phosphate","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Androgen receptor, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"ropivacaine","indication_name":"Major Nerve Block for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Naropin","generic_name":"ROPIVACAINE","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"Sodium channel protein type 5 subunit alpha","drug_class":"Amide Local Anesthetic","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"neostigmine","indication_name":"Reversal of neuromuscular blockade","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bloxiverz","generic_name":"NEOSTIGMINE","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"Cholinesterase Inhibitor","quality_score":75,"revenue":null,"mechanism":"Bloxiverz works by blocking the enzyme acetylcholinesterase, allowing more acetylcholine to be available in the nervous system."},{"drug_id":"mepivacaine","indication_name":"Administration of Local Anesthetic Nerve Block","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Carbocaine","generic_name":"MEPIVACAINE","company_name":"Eastman Kodak","drug_phase":"marketed","molecular_target":"Sodium channel protein type 1 subunit alpha","drug_class":"Amide Local Anesthetic","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"bupivacaine","indication_name":"Local anesthetic intrathecal block","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"BUPIVACAINE","company_name":"Innocoll","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Amide Local Anesthetic","quality_score":69,"revenue":null,"mechanism":"Bupivacaine works by blocking nerve impulses to prevent pain signals from reaching the brain."},{"drug_id":"bupivacaine","indication_name":"Major Nerve Block for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"BUPIVACAINE","company_name":"Innocoll","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Amide Local Anesthetic","quality_score":69,"revenue":null,"mechanism":"Bupivacaine works by blocking nerve impulses to prevent pain signals from reaching the brain."},{"drug_id":"non-interventional-study","indication_name":"Heart Block","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non-Interventional Study","generic_name":"non-interventional-study","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Vitamin K epoxide reductase","drug_class":"Anticoagulant","quality_score":25,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":38,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06119009","title":"New-onset Heart Blocks After Noncardiac Surgery: a Retrospective Study of More Than 280,000 Patients","phase":"","overall_status":"COMPLETED","enrollment_count":281497,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT03585348","title":"Provider Variability in the Use of Neuromuscular Blocking Drugs and Reversal","phase":"","overall_status":"COMPLETED","enrollment_count":265537,"lead_sponsor_name":"Beth Israel Deaconess Medical Center","has_results":false},{"nct_id":"NCT05471882","title":"Predicting Neuromuscular Recovery in Surgical Patients Using Machine Learning","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":240000,"lead_sponsor_name":"University Hospital Ulm","has_results":false},{"nct_id":"NCT03585400","title":"Validation of the REPS Prediction Tool","phase":"","overall_status":"COMPLETED","enrollment_count":101510,"lead_sponsor_name":"Beth Israel Deaconess Medical Center","has_results":false},{"nct_id":"NCT06948409","title":"NMBA Reversal and Postoperative Urinary Retention","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":70000,"lead_sponsor_name":"Beth Israel Deaconess Medical Center","has_results":false},{"nct_id":"NCT02914119","title":"Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals","phase":"","overall_status":"COMPLETED","enrollment_count":30430,"lead_sponsor_name":"Jakob Louis Thomsen","has_results":true},{"nct_id":"NCT06763549","title":"COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":15000,"lead_sponsor_name":"Peerbridge Health, Inc","has_results":false},{"nct_id":"NCT04451642","title":"A Retrospective Clinical Registry of Peripheral Nerve Block","phase":"","overall_status":"COMPLETED","enrollment_count":13816,"lead_sponsor_name":"Instituto de Investigación Sanitaria Aragón","has_results":false},{"nct_id":"NCT06324682","title":"ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing","phase":"","overall_status":"RECRUITING","enrollment_count":8400,"lead_sponsor_name":"University Hospital of Ferrara","has_results":false},{"nct_id":"NCT02925143","title":"Improving Neuromuscular Monitoring and Reducing Residual Neuromuscular Blockade Via E-learning","phase":"NA","overall_status":"COMPLETED","enrollment_count":6525,"lead_sponsor_name":"Herlev Hospital","has_results":true},{"nct_id":"NCT05788718","title":"An Observational Study to Analyze the Prescription Pattern of Sugammadex and Its Effectiveness and Safety","phase":"","overall_status":"COMPLETED","enrollment_count":6458,"lead_sponsor_name":"Boryung Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT06829108","title":"Association of Transversus Abdominis Plane Block (TAPB) with Postoperative Delirium (POD) in Elderly Patients Undergoing Major Gastrointestinal Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":5220,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT05903313","title":"A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software","phase":"","overall_status":"UNKNOWN","enrollment_count":4306,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT07238933","title":"Neurological Events and Unforeseen Risks After Locoregional-anesthesia","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":3396,"lead_sponsor_name":"Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva","has_results":false},{"nct_id":"NCT06238219","title":"Management of Neuromuscular Blocking Agents and Their Antagonism","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Erasme University Hospital","has_results":false},{"nct_id":"NCT03128151","title":"Reducing the Incidence of PostOperative Residual Curarization","phase":"","overall_status":"COMPLETED","enrollment_count":2314,"lead_sponsor_name":"Oscar Diaz-Cambronero","has_results":false},{"nct_id":"NCT05650658","title":"Left vs Left Randomized Clinical Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":2136,"lead_sponsor_name":"Baylor College of Medicine","has_results":false},{"nct_id":"NCT05528029","title":"International Ledless Pacemaker Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Luigi Sacco University Hospital","has_results":false},{"nct_id":"NCT04293471","title":"Prediction of Outcome by Echocardiography in Left Bundle Branch Block","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"University Hospital of North Norway","has_results":false},{"nct_id":"NCT06964464","title":"Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"University of Rochester","has_results":false},{"nct_id":"NCT07367386","title":"Impact of Increasing BMI on the Success of Neuraxial Blocks in Class III Obese Parturients","phase":"","overall_status":"COMPLETED","enrollment_count":1917,"lead_sponsor_name":"Mariah Arif","has_results":false},{"nct_id":"NCT03086915","title":"Myorelaxation Practice in Paediatric Anesthesia","phase":"","overall_status":"COMPLETED","enrollment_count":1650,"lead_sponsor_name":"Brno University Hospital","has_results":false},{"nct_id":"NCT06246331","title":"Evaluation of the Clinical Efficacy and Safety of BriTurn Injection or BrisTurn Prefilled Injection","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Hanlim Pharm. Co., Ltd.","has_results":false},{"nct_id":"NCT04548713","title":"CLiCK in the Critical Care Unit","phase":"NA","overall_status":"COMPLETED","enrollment_count":1449,"lead_sponsor_name":"Fraser Health","has_results":false},{"nct_id":"NCT04474223","title":"Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1300,"lead_sponsor_name":"NYU Langone Health","has_results":false},{"nct_id":"NCT05015660","title":"Conduction System Pacing With Left Bundle Branch Pacing as Compared to Standard Right Ventricular Pacing","phase":"NA","overall_status":"RECRUITING","enrollment_count":1300,"lead_sponsor_name":"McGill University Health Centre/Research Institute of the McGill University Health Centre","has_results":false},{"nct_id":"NCT05018104","title":"Risk Model for Severe Rebound Pain After Lower Limb Orthopedic Surgery Involving Single-Shot Sciatic Nerve Blocks","phase":"","overall_status":"COMPLETED","enrollment_count":1270,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT07279870","title":"RandomIsed sTudy of Physiologic cArdiac stimuLation in patIents With Atrio-ventricular Conduction Disease","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1260,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT01422304","title":"Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1198,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT07347067","title":"Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Migraine","phase":"NA","overall_status":"RECRUITING","enrollment_count":1036,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT07084363","title":"Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery","phase":"NA","overall_status":"RECRUITING","enrollment_count":1032,"lead_sponsor_name":"The University of Texas Health Science Center, Houston","has_results":false},{"nct_id":"NCT02809131","title":"Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1010,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":true},{"nct_id":"NCT03280862","title":"DANISH-CRT - Does Electric Targeted LV Lead Positioning Improve Outcome in Patients With Heart Failure and Prolonged QRS","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Aarhus University Hospital","has_results":false},{"nct_id":"NCT07171502","title":"AI-Assisted Ultrasound-Guided Nerve Block: Model Development and Performance Assessment","phase":"NA","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Shanghai Jiao Tong University Affiliated Sixth People's Hospital","has_results":false},{"nct_id":"NCT05722379","title":"Left Bundle Branch Pacing Versus Right Ventricular Pacing in Patients With Atrioventricular Block","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT03497611","title":"Edwards SAPIEN 3 PPI Registry","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Institut für Pharmakologie und Präventive Medizin","has_results":false},{"nct_id":"NCT05283603","title":"Clinical Observational Registry of Patients With Left Bundle Branch Block","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Azienda Ospedaliero Universitaria di Sassari","has_results":false},{"nct_id":"NCT07196397","title":"POLish Registry of CArdioneuroablation and CArdioneuromodulation","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"SABAMED Medical Center Ltd.","has_results":false},{"nct_id":"NCT03719040","title":"Physiologic Pacing Registry","phase":"","overall_status":"COMPLETED","enrollment_count":870,"lead_sponsor_name":"Abbott Medical Devices","has_results":true},{"nct_id":"NCT04508244","title":"Beta Blocker Use In Traumatic Brain Injury Based On The High-Sensitive Troponin T Status","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":771,"lead_sponsor_name":"Hamad Medical Corporation","has_results":false},{"nct_id":"NCT04124757","title":"Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety","phase":"NA","overall_status":"COMPLETED","enrollment_count":731,"lead_sponsor_name":"Leiden University Medical Center","has_results":true},{"nct_id":"NCT06652750","title":"Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices","phase":"NA","overall_status":"RECRUITING","enrollment_count":688,"lead_sponsor_name":"The Third People's Hospital of Chengdu","has_results":false},{"nct_id":"NCT04259112","title":"Effect of Pneumoperitoneum and Neuromuscular Block on Renal Function in Diabetes Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":648,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06216002","title":"Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery","phase":"NA","overall_status":"RECRUITING","enrollment_count":622,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT06023784","title":"The Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricular Block","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":530,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT03096678","title":"Prognosis of Patients With Compete Left Bundle Branch Block","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Chinese Academy of Medical Sciences, Fuwai Hospital","has_results":false},{"nct_id":"NCT06165991","title":"Liposomal and Standard Bupivacaine in Thoracic Paravertebral Block for Post-Thoracoscopic Pain","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":496,"lead_sponsor_name":"Yongtao Sun","has_results":false},{"nct_id":"NCT07203287","title":"Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":490,"lead_sponsor_name":"The University of Texas Medical Branch, Galveston","has_results":false},{"nct_id":"NCT04730921","title":"Impact of Left Bundle Branch Area Pacing vs. Right Ventricular Pacing in Atrioventricular Block (LEAP-Block)","phase":"NA","overall_status":"COMPLETED","enrollment_count":486,"lead_sponsor_name":"Fu Wai Hospital, Beijing, China","has_results":false},{"nct_id":"NCT04595487","title":"LVSP vs RVP in Patients With AV Conduction Disorders","phase":"NA","overall_status":"RECRUITING","enrollment_count":470,"lead_sponsor_name":"Maastricht University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}